Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | Case report

Bevacizumab/pembrolizumab

Small joint arthritis in both the hands following off label use: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Lin Y-C, et al. Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report. Journal of Ovarian Research 13: No. 1, Dec 2020. Available from: URL: http://doi.org/10.1186/s13048-020-00751-3 Lin Y-C, et al. Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report. Journal of Ovarian Research 13: No. 1, Dec 2020. Available from: URL: http://​doi.​org/​10.​1186/​s13048-020-00751-3
Metadaten
Titel
Bevacizumab/pembrolizumab
Small joint arthritis in both the hands following off label use: case report
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-87994-7

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Lidocaine

Case report

Eltrombopag

Case report

Trametinib

Case report

Amphotericin-B